TG Therapeutics GAAP EPS of -$0.07 misses by $0.03, revenue of $63.47M beats by $8.86M
TG Therapeutics press release (NASDAQ:TGTX): Q1 GAAP EPS of -$0.07 misses by $0.03. Revenue of
TG Therapeutics press release (NASDAQ:TGTX): Q1 GAAP EPS of -$0.07 misses by $0.03. Revenue of
Summary: Palantir’s stock is up 13% since our bullish call in November, in line with